Stock DNA
Pharmaceuticals & Biotechnology
CNY 6,795 Million (Mid Cap)
27.00
NA
1.35%
-0.21
7.30%
1.98
Revenue and Profits:
Net Sales:
342 Million
(Quarterly Results - Jun 2025)
Net Profit:
94 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
10.31%
0%
10.31%
6 Months
39.02%
0%
39.02%
1 Year
38.75%
0%
38.75%
2 Years
2.47%
0%
2.47%
3 Years
-12.51%
0%
-12.51%
4 Years
-26.75%
0%
-26.75%
5 Years
-63.48%
0%
-63.48%
Chengdu Kanghua Biological Products Co., Ltd. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
9.68%
EBIT Growth (5y)
-3.53%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.22
Sales to Capital Employed (avg)
0.40
Tax Ratio
14.30%
Dividend Payout Ratio
33.03%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
28.87%
ROE (avg)
16.97%
Valuation key factors
Factor
Value
P/E Ratio
27
Industry P/E
Price to Book Value
1.98
EV to EBIT
21.93
EV to EBITDA
17.60
EV to Capital Employed
2.24
EV to Sales
5.22
PEG Ratio
NA
Dividend Yield
1.35%
ROCE (Latest)
10.19%
ROE (Latest)
7.30%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bullish
Mildly Bullish
Moving Averages
Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
Mildly Bullish
Mildly Bullish
OBV
Mildly Bullish
Mildly Bullish
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Jun'25 - YoY
Jun'25
Jun'24
Change(%)
Net Sales
341.90
425.90
-19.72%
Operating Profit (PBDIT) excl Other Income
121.40
203.20
-40.26%
Interest
0.90
1.30
-30.77%
Exceptional Items
1.80
-5.10
135.29%
Consolidate Net Profit
93.80
157.10
-40.29%
Operating Profit Margin (Excl OI)
293.60%
420.10%
-12.65%
USD in Million.
Net Sales
YoY Growth in quarter ended Jun 2025 is -19.72% vs 20.65% in Jun 2024
Consolidated Net Profit
YoY Growth in quarter ended Jun 2025 is -40.29% vs 9.86% in Jun 2024
Annual Results Snapshot (Consolidated) - Dec'24
Dec'24
Dec'23
Change(%)
Net Sales
1,421.60
1,567.60
-9.31%
Operating Profit (PBDIT) excl Other Income
591.10
660.80
-10.55%
Interest
5.40
4.90
10.20%
Exceptional Items
-59.70
-31.90
-87.15%
Consolidate Net Profit
398.70
509.20
-21.70%
Operating Profit Margin (Excl OI)
363.30%
382.10%
-1.88%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2024 is -9.31% vs 8.97% in Dec 2023
Consolidated Net Profit
YoY Growth in year ended Dec 2024 is -21.70% vs -14.86% in Dec 2023
About Chengdu Kanghua Biological Products Co., Ltd. 
Chengdu Kanghua Biological Products Co., Ltd.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available






